This critical appraisal analyzes a 2-year randomized controlled trial for schizophrenia treatment, comparing integrated care to routine treatment. The study's methodology, results, and ethical considerations are discussed. The study employed a randomized control trial over two years to compare different schizophrenia management approaches. The data analysis method of the study has been adequately documented and presented in the order of analysis from the first one to the last. The findings of the study have been well presented in seven themes with each theme scoring a high confidence level of P<0.05. The discussion section of the study draws from the work of other authors and presents the limitations of the study to justify the factors that may limit the reliability and generalization of the findings. The recommendations section of the study forms the basis for integrating the findings of the study with the existing knowledge to form directions for future practice.